+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ethicon US LLC - Product Pipeline Analysis, 2018 Update

  • ID: 4042931
  • Company Profile
  • Region: United States
  • 45 pages
  • GlobalData
  • Ethicon Inc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Aesculap Inc
  • ConMed Corporation
  • Medtronic Plc
  • Rex Medical LP
  • Sanovas Inc
  • Stryker Corp
  • MORE
Ethicon US LLC (Ethicon), a subsidiary of Johnson and Johnson, is a medical equipment company which operates through Ethicon Inc, and Ethicon Endo-Surgery Inc. It develops and markets surgical instruments and devices. Its major products include staplers, energy devices, clip appliers, trocars, hemostats, endocutters, suturing devices, endoscopic instruments, electrosurgical and irrigation products, meshes and allografts. Its products are used in minimally invasive and open surgical procedures to treat colorectal, thoracic, and women’s health conditions, hernias, cancer and obesity. Ethicon also offers ultrasonic energy devices and advanced bipolar energy devices. The company has medical education and surgical training, manufacturing, and sales facilities in the Americas, Europe and Asia-Pacific. Ethicon is headquartered in Cincinnati, Ohio, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Ethicon US LLC
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Aesculap Inc
  • ConMed Corporation
  • Medtronic Plc
  • Rex Medical LP
  • Sanovas Inc
  • Stryker Corp
  • MORE
  • Ethicon US LLC Company Overview
  • Ethicon US LLC Company Snapshot
  • Ethicon US LLC Pipeline Products and Ongoing Clinical Trials Overview
  • Ethicon US LLC - Pipeline Analysis Overview
  • Business Description
  • Ethicon US LLC - Key Facts
  • Ethicon US LLC - Major Products and Services
  • Ethicon US LLC Pipeline Products by Development Stage
  • Ethicon US LLC Ongoing Clinical Trials by Trial Status
  • Ethicon US LLC Pipeline Products Overview
  • Additional PLUS Barbed Suture
  • Additional PLUS Barbed Suture Product Overview
  • Flowable thrombin
  • Flowable thrombin Product Overview
  • Gynecare GynOcclude
  • Gynecare GynOcclude Product Overview
  • GYNECARE SUI Sling Next Generation
  • GYNECARE SUI Sling Next Generation Product Overview
  • Next Gen Automated Endoscope Reprocessor
  • Next Gen Automated Endoscope Reprocessor Product Overview
  • Next Gen Hemostat Kit
  • Next Gen Hemostat Kit Product Overview
  • PRINEO Next Generation
  • PRINEO Next Generation Product Overview
  • Robotic-assisted Surgical Device
  • Robotic-assisted Surgical Device Product Overview
  • SURGIFLO - Sterile Field Preparation
  • SURGIFLO - Sterile Field Preparation Product Overview
  • VICRYL (Polydactin 910) - Next Gen
  • VICRYL (Polydactin 910) - Next Gen Product Overview
  • VICRYL (Polydactin 910) - Next Gen Clinical Trial
  • Vicryl Rapide Plus Suture
  • Vicryl Rapide Plus Suture Product Overview
  • Vicryl Rapide Plus Suture Clinical Trial
  • Ethicon US LLC - Key Competitors
  • Ethicon US LLC - Key Employees
  • Ethicon US LLC - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Business Unit
  • Recent Developments
  • Ethicon US LLC, Recent Developments
  • Mar 26, 2018: Ethicon Highlights New Capabilities to Reduce Exposure to Surgical Smoke at the Association of PeriOperative Nurses (AORN) Conference
  • Jan 09, 2018: New Absorbable Adjunctive Hemostat from Ethicon Helps Surgeons Control Disruptive Bleeding more Efficiently
  • Dec 13, 2017: Ethicon Transvaginal Mesh Lawsuit Goes to Trial in New Jersey, Bernstein Liebhard LLP Reports
  • Nov 10, 2017: Ethicon's BIOPATCH Protective Disk with CHG Meets New CDC Recommendation and Continues as the Standard of Care to Reduce Intravascular Catheter-related Blood Stream Infections
  • Nov 06, 2017: Ethicon Celebrates 130 Years of Transforming Surgery to Advance Patient Outcomes
  • Nov 03, 2017: Johnson & Johnson wins Contract for Medical Surgical Products
  • Oct 31, 2017: Ethicon Showcases Leading Edge Solutions Beyond The O.R. To Empower Patients And Providers In Fight Against Obesity At ObesityWeek 2017
  • Aug 31, 2017: Ethicon Highlights the Importance of Choice, at IFSO 2017
  • Aug 30, 2017: Ethicon Reports Major Progress On Multi-Year Initiative To Fill Clinical And Economic Evidence Gaps And Expand Access To Bariatric Surgery
  • Aug 07, 2017: Ethicon Transvaginal Mesh Lawsuits Move Forward in Pennsylvania, As Sixth Trial Kicks Off in Philadelphia, Bernstein Liebhard Reports
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • Ethicon US LLC Pipeline Products and Ongoing Clinical Trials Overview
  • Ethicon US LLC Pipeline Products by Equipment Type
  • Ethicon US LLC Pipeline Products by Indication
  • Ethicon US LLC Ongoing Clinical Trials by Trial Status
  • Ethicon US LLC, Key Facts
  • Ethicon US LLC, Major Products and Services
  • Ethicon US LLC Number of Pipeline Products by Development Stage
  • Ethicon US LLC Pipeline Products Summary by Development Stage
  • Ethicon US LLC Ongoing Clinical Trials by Trial Status
  • Ethicon US LLC Ongoing Clinical Trials Summary
  • Additional PLUS Barbed Suture - Product Status
  • Additional PLUS Barbed Suture - Product Description
  • Flowable thrombin - Product Status
  • Flowable thrombin - Product Description
  • Gynecare GynOcclude - Product Status
  • Gynecare GynOcclude - Product Description
  • GYNECARE SUI Sling Next Generation - Product Status
  • GYNECARE SUI Sling Next Generation - Product Description
  • Next Gen Automated Endoscope Reprocessor - Product Status
  • Next Gen Automated Endoscope Reprocessor - Product Description
  • Next Gen Hemostat Kit - Product Status
  • Next Gen Hemostat Kit - Product Description
  • PRINEO Next Generation - Product Status
  • PRINEO Next Generation - Product Description
  • Robotic-assisted Surgical Device - Product Status
  • Robotic-assisted Surgical Device - Product Description
  • SURGIFLO - Sterile Field Preparation - Product Status
  • SURGIFLO - Sterile Field Preparation - Product Description
  • VICRYL (Polydactin 910) - Next Gen - Product Status
  • VICRYL (Polydactin 910) - Next Gen - Product Description
  • VICRYL (Polydactin 910) - Next Gen - Comparison of Barbed and Conventional Sutures in Adhesion Formation Following Cesarean Section: A Randomized Controlled Study
  • VICRYL (Polydactin 910) - Next Gen - Comparison of Robot-assisted Laparoscopic Myomectomy and Traditional Laparoscopic Myomectomy with Barbed Sutures
  • Vicryl Rapide Plus Suture - Product Status
  • Vicryl Rapide Plus Suture - Product Description
  • Vicryl Rapide Plus Suture - Comparison of Barbed and Conventional Sutures in Adhesion Formation Following Cesarean Section: A Randomized Controlled Study
  • Vicryl Rapide Plus Suture - Comparison of Robot-assisted Laparoscopic Myomectomy and Traditional Laparoscopic Myomectomy with Barbed Sutures
  • Ethicon US LLC, Key Employees
  • Ethicon US LLC, Other Locations
  • Ethicon US LLC, Subsidiaries
  • Ethicon US LLC, Business Unit
  • Glossary
List of Figures
  • Ethicon US LLC Pipeline Products by Equipment Type
  • Ethicon US LLC Pipeline Products by Development Stage
  • Ethicon US LLC Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Surgical Innovations Group Plc
  • ConMed Corporation
  • Medtronic Plc
  • Sanovas Inc
  • Aesculap Inc
  • Rex Medical LP
  • Stryker Corp
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4042931
Adroll
adroll